应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TWST Twist Bioscience Corp
劳工日休市 09-04 16:00:00 EDT
124.72
-3.99
-3.10%
盘后
124.70
-0.02
-0.02%
19:30 EDT
最高
128.13
最低
123.75
成交量
90.19万
今开
125.19
昨收
128.71
日振幅
3.40%
总市值
82.11亿
流通市值
77.03亿
总股本
6,583万
成交额
1.13亿
换手率
1.46%
流通股本
6,176万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|Twist Bioscience盘中上涨5.15%,Anthropic AI蛋白质设计合作持续催化
行情直击 · 09-02
异动解读|Twist Bioscience盘中上涨5.15%,Anthropic AI蛋白质设计合作持续催化
异动解读|Twist Bioscience盘中下跌5.01%,报132.12美元
行情直击 · 09-02
异动解读|Twist Bioscience盘中下跌5.01%,报132.12美元
异动解读|Twist Bioscience盘中下跌5.17%,报145.19美元
行情直击 · 08-28
异动解读|Twist Bioscience盘中下跌5.17%,报145.19美元
异动解读|Twist Bioscience盘中上涨5.03%,Anthropic蛋白质设计合作持续催化股价走强
行情直击 · 08-25
异动解读|Twist Bioscience盘中上涨5.03%,Anthropic蛋白质设计合作持续催化股价走强
异动解读|Twist Bioscience盘中下跌5.58%,报138.505美元
行情直击 · 08-24
异动解读|Twist Bioscience盘中下跌5.58%,报138.505美元
异动解读|Twist Bioscience盘中上涨5.07%,Anthropic蛋白质设计合作持续催化股价走强
行情直击 · 08-22
异动解读|Twist Bioscience盘中上涨5.07%,Anthropic蛋白质设计合作持续催化股价走强
异动解读|Twist Bioscience盘中上涨12.21%,生物科技板块大涨叠加强劲Q4指引催化超跌反弹
行情直击 · 08-19
异动解读|Twist Bioscience盘中上涨12.21%,生物科技板块大涨叠加强劲Q4指引催化超跌反弹
异动解读|Twist Bioscience盘前上涨5.65%,强劲Q4营收指引支撑超跌反弹
行情直击 · 08-19
异动解读|Twist Bioscience盘前上涨5.65%,强劲Q4营收指引支撑超跌反弹
异动解读|Twist Bioscience盘中下跌5.37%,报117.73美元
行情直击 · 08-18
异动解读|Twist Bioscience盘中下跌5.37%,报117.73美元
异动解读|Twist Bioscience盘中上涨5.07%,强劲财报指引与AI制药需求持续提振
行情直击 · 08-18
异动解读|Twist Bioscience盘中上涨5.07%,强劲财报指引与AI制药需求持续提振
异动解读|Twist Bioscience盘中下跌5.36%,报118.58美元
行情直击 · 08-14
异动解读|Twist Bioscience盘中下跌5.36%,报118.58美元
异动解读|Twist Bioscience盘中上涨5.04%,AI赋能药物发现叙事叠加强劲营收指引持续推升股价
行情直击 · 08-10
异动解读|Twist Bioscience盘中上涨5.04%,AI赋能药物发现叙事叠加强劲营收指引持续推升股价
异动解读|Twist Bioscience盘中上涨5.43%,营收指引大超预期推动股价高位震荡反弹
行情直击 · 08-07
异动解读|Twist Bioscience盘中上涨5.43%,营收指引大超预期推动股价高位震荡反弹
异动解读|Twist Bioscience盘中下跌5.1%,财报多空分歧延续股价高位回调
行情直击 · 08-07
异动解读|Twist Bioscience盘中下跌5.1%,财报多空分歧延续股价高位回调
异动解读|Twist Bioscience盘中上涨6.59%,营收指引大超预期持续提振市场信心
行情直击 · 08-05
异动解读|Twist Bioscience盘中上涨6.59%,营收指引大超预期持续提振市场信心
异动解读|Twist Bioscience盘前上涨5.45%,营收指引大超预期提振市场信心
行情直击 · 08-05
异动解读|Twist Bioscience盘前上涨5.45%,营收指引大超预期提振市场信心
异动解读 | 业绩展望乐观,Twist Bioscience Corp盘中大涨5.16%
异动解读 · 08-03
异动解读 | 业绩展望乐观,Twist Bioscience Corp盘中大涨5.16%
异动解读|Twist Bioscience盘中下跌9.51%,财季业绩由盈转亏且超预期恶化
行情直击 · 08-03
异动解读|Twist Bioscience盘中下跌9.51%,财季业绩由盈转亏且超预期恶化
异动解读 | 盈利由盈转亏且超预期恶化,Twist Bioscience盘前大跌6.22%
异动解读 · 08-03
异动解读 | 盈利由盈转亏且超预期恶化,Twist Bioscience盘前大跌6.22%
异动解读|Twist Bioscience盘前下跌6.22%,财季亏损超预期拖累股价
行情直击 · 08-03
异动解读|Twist Bioscience盘前下跌6.22%,财季亏损超预期拖累股价
加载更多
公司概况
公司名称:
Twist Bioscience Corp
所属市场:
NASDAQ
上市日期:
--
主营业务:
Twist Bioscience Corporation于2013年2月4日在特拉华州注册成立。该公司致力于为那些正在把世界变得更好的客户服务。在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域,客户正在利用他们的合成DNA工具开发改善生活和改善地球可持续性的方法。他们开发了一个颠覆性的DNA合成平台,使生物学工程产业化,为广泛的用途和市场提供DNA。他们将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合起来,创建了一个集成的技术平台。
发行价格:
--
{"stockData":{"symbol":"TWST","market":"US","secType":"STK","nameCN":"Twist Bioscience Corp","latestPrice":124.72,"timestamp":1788552000000,"preClose":128.71,"halted":0,"volume":901850,"hourTrading":{"tag":"盘后","latestPrice":124.7,"preClose":124.72,"latestTime":"19:30 EDT","volume":18367,"amount":2290633.66,"timestamp":1788564652445,"change":-0.02,"changeRate":-0.00016,"amplitude":0.00103},"delay":0,"changeRate":-0.0309999223059592,"floatShares":61759503,"shares":65832424,"eps":-2.229262,"marketStatus":"劳工日休市","change":-3.99,"latestTime":"09-04 16:00:00 EDT","open":125.19,"high":128.125,"low":123.75,"amount":112690062.5105,"amplitude":0.033991,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.229262,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1540958400000,"exchange":"NASDAQ","adjPreClose":128.71,"preHourTrading":{"tag":"盘前","latestPrice":129.3,"preClose":128.71,"latestTime":"09:29 EDT","volume":1594,"amount":204140.26447999998,"timestamp":1788528563852,"change":0.59,"changeRate":0.004584,"amplitude":0.057027},"postHourTrading":{"tag":"盘后","latestPrice":124.7,"preClose":124.72,"latestTime":"19:30 EDT","volume":18367,"amount":2290633.66,"timestamp":1788564652445,"change":-0.02,"changeRate":-0.00016,"amplitude":0.00103},"volumeRatio":0.600040532787558,"impliedVol":0.7623,"impliedVolPercentile":0.4802},"requestUrl":"/m/hq/s/TWST","defaultTab":"news","newsList":[{"id":"1159488514","title":"异动解读|Twist Bioscience盘中上涨5.15%,Anthropic AI蛋白质设计合作持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1159488514","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159488514?lang=zh_cn&edition=full","pubTime":"2026-09-02 21:47","pubTimestamp":1788356829,"startTime":"0","endTime":"0","summary":"9月2日,Twist Bioscience盘中上涨5.15%,报138.86美元/股,成交额2112.25万美元。该股早盘一度下挫近5%后快速反弹。消息面上,Anthropic此前公布基于Claude大模型的蛋白质设计成果,在几乎无人工干预的条件下自主设计出14个临床靶点的蛋白结合剂,整体命中率达22.6%至35.1%,远超行业水平。Twist Bioscience作为独立实验验证平台之一,负责大规模快速合成AI设计蛋白并完成结合能力测试,该消息此前已推动股价单日大涨逾17%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AI蛋白质设计合作催化,Twist Bioscience盘中上涨","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119397394","title":"异动解读|Twist Bioscience盘中下跌5.01%,报132.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119397394","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119397394?lang=zh_cn&edition=full","pubTime":"2026-09-02 02:47","pubTimestamp":1788288425,"startTime":"0","endTime":"0","summary":"9月2日,Twist Bioscience盘中下跌5.01%,报132.12美元/股,成交额1.06亿美元。Twist Bioscience所在的生物科技行业中,个股中,Moderna涨6.43%,艾伯维涨1.51%,安进涨1.52%,吉利德科学涨1.72%,bioAffinity Technologies涨43.64%。Twist Bioscience是一家专注于合成生物学的科技公司,致力于DNA合成平台的开发,将基于硅的DNA编写技术与专有软件结合,为医疗保健、食品农业、工业化学品及数据存储等领域客户提供合成DNA工具。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145511959","title":"异动解读|Twist Bioscience盘中下跌5.17%,报145.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145511959","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145511959?lang=zh_cn&edition=full","pubTime":"2026-08-28 23:45","pubTimestamp":1787931910,"startTime":"0","endTime":"0","summary":"8月28日,Twist Bioscience盘中下跌5.17%,报145.19美元/股,成交额6810.62万美元。Twist Bioscience所在的生物科技行业中,个股表现分化,其中Moderna下跌4.07%,BioNTech下跌7.46%,Quoin Pharmaceuticals上涨23.76%,安进下跌0.97%,Hyperliquid Strategies Inc上涨1.32%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156101013","title":"异动解读|Twist Bioscience盘中上涨5.03%,Anthropic蛋白质设计合作持续催化股价走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1156101013","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156101013?lang=zh_cn&edition=full","pubTime":"2026-08-25 21:43","pubTimestamp":1787665401,"startTime":"0","endTime":"0","summary":"8月25日,Twist Bioscience盘中上涨5.03%,报147.74美元/股,成交额836.28万美元,在前一交易日回调5.58%后强势反弹。消息面上,公司于8月20日披露被Anthropic选为多臂AI蛋白质设计项目的独立评估机构,负责大规模快速生产AI设计的蛋白质并测试其结合能力。Anthropic利用Claude Opus 4.8和Mythos Preview针对15个靶点开展蛋白质设计实验,Twist Bioscience作为外部评估方的角色进一步夯实了其在AI制药产业链中DNA合成及蛋白质生产环节的核心供应商地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘中上涨,Anthropic合作持续催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197021399","title":"异动解读|Twist Bioscience盘中下跌5.58%,报138.505美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197021399","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197021399?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:46","pubTimestamp":1787579168,"startTime":"0","endTime":"0","summary":"8月24日,Twist Bioscience盘中下跌5.58%,报138.505美元/股,成交额1605.37万美元。Twist Bioscience所在的生物科技行业中,个股表现分化,其中Moderna下跌7.26%,艾伯维公司下跌0.18%,安进上涨0.15%,Hyperliquid Strategies Inc上涨0.57%,阿尔尼拉姆制药公司下跌1.84%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143755657","title":"异动解读|Twist Bioscience盘中上涨5.07%,Anthropic蛋白质设计合作持续催化股价走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1143755657","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143755657?lang=zh_cn&edition=full","pubTime":"2026-08-22 00:56","pubTimestamp":1787331404,"startTime":"0","endTime":"0","summary":"8月21日,Twist Bioscience盘中上涨5.07%,报143.245美元/股,成交额1.0亿美元,延续前一交易日大涨逾22%的强势表现。消息面上,公司于8月20日披露被Anthropic选为多臂AI蛋白质设计项目的独立评估机构,负责大规模快速生产AI设计的蛋白质并测试其结合能力。Anthropic利用Claude Opus 4.8和Mythos Preview针对15个靶点开展蛋白质设计实验,Twist Bioscience作为外部评估方的角色进一步夯实了其在AI制药产业链中DNA合成及蛋白质生产环节的核心供应商地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist获Anthropic合作,AI制药催化上涨","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181222559","title":"异动解读|Twist Bioscience盘中上涨12.21%,生物科技板块大涨叠加强劲Q4指引催化超跌反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1181222559","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181222559?lang=zh_cn&edition=full","pubTime":"2026-08-19 21:36","pubTimestamp":1787146607,"startTime":"0","endTime":"0","summary":"8月19日,Twist Bioscience盘中上涨12.21%,报134.92美元/股,成交额4549.12万美元。前一交易日该股收跌6.68%至116.10美元,今日在生物科技板块整体大涨带动下强势反弹。板块层面,同行业个股中Moderna大涨92.12%、BioNTech涨16.46%、吉利德科学涨2.04%,行业情绪显著回暖。基本面上,公司8月3日发布的第三季度财报显示营收1.184亿美元,超出市场预期;同时第四季度营收指引1.23亿至1.24亿美元,大幅高于市场预估的1.174亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175529436","title":"异动解读|Twist Bioscience盘前上涨5.65%,强劲Q4营收指引支撑超跌反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1175529436","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175529436?lang=zh_cn&edition=full","pubTime":"2026-08-19 19:37","pubTimestamp":1787139447,"startTime":"0","endTime":"0","summary":"8月19日,Twist Bioscience盘前上涨5.65%,报122.66美元/股,成交额157.23万美元。前一交易日该股收跌6.68%至116.10美元,盘前出现明显修复。消息面上,公司8月3日发布的第三季度财报显示营收1.184亿美元,超出市场预期;同时第四季度营收指引1.23亿至1.24亿美元,大幅高于市场预估的1.174亿美元。作为AI制药产业链中DNA合成环节核心供应商,公司蛋白业务增速显著,叠加此前完成3亿美元增发扩充产能,基本面持续改善支撑股价在前日急跌后技术性反弹。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195044573","title":"异动解读|Twist Bioscience盘中下跌5.37%,报117.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195044573","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195044573?lang=zh_cn&edition=full","pubTime":"2026-08-18 23:05","pubTimestamp":1787065542,"startTime":"0","endTime":"0","summary":"8月18日,Twist Bioscience盘中下跌5.37%,报117.73美元/股,成交额4956.28万美元。Twist Bioscience所在的生物科技行业中,个股中,艾伯维公司涨2.46%,安进涨1.0%,吉利德科学涨2.78%,福泰制药涨1.96%,Revolution Medicines跌0.24%。Twist Bioscience Corp是一家合成生物学公司,开发了一种颠覆性的DNA合成平台,以实现生物学工程的工业化,将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合,在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域为客户提供合成DNA工具。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133180186","title":"异动解读|Twist Bioscience盘中上涨5.07%,强劲财报指引与AI制药需求持续提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1133180186","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133180186?lang=zh_cn&edition=full","pubTime":"2026-08-18 03:59","pubTimestamp":1786996761,"startTime":"0","endTime":"0","summary":"8月18日,Twist Bioscience盘中上涨5.07%,报124.49美元/股,成交额9744.33万美元。消息面上,公司8月3日发布的第三季度财报显示营收1.184亿美元,超出市场预期的1.145亿美元;同时公司给出第四季度营收指引1.23亿至1.24亿美元,大幅高于市场预估的1.174亿美元。作为AI制药产业链中DNA合成环节的核心供应商,公司深度绑定AI药物发现需求,蛋白业务增速显著,叠加完成3亿美元增发扩充产能,基本面持续改善推动股价在前期回调后反弹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175048021","title":"异动解读|Twist Bioscience盘中下跌5.36%,报118.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175048021","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175048021?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:57","pubTimestamp":1786719446,"startTime":"0","endTime":"0","summary":"8月14日,Twist Bioscience盘中下跌5.36%,报118.58美元/股,成交额5637.99万美元。Twist Bioscience所在的生物科技行业中,个股中,Capricor Therapeutics Inc涨66.75%,MDxHealth涨78.2%,艾伯维公司跌1.03%,Natera跌0.69%,安进跌1.6%。Twist Bioscience Corp是一家合成生物学公司,开发了一种颠覆性的DNA合成平台,以实现生物学工程的工业化,将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合,在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域为客户提供合成DNA工具。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120636811","title":"异动解读|Twist Bioscience盘中上涨5.04%,AI赋能药物发现叙事叠加强劲营收指引持续推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1120636811","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120636811?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:59","pubTimestamp":1786370344,"startTime":"0","endTime":"0","summary":"8月10日,Twist Bioscience盘中上涨5.04%,报121.5046美元/股,成交额4905.15万美元。消息面上,市场持续关注AI赋能药物发现对公司的价值重估。公司在AI驱动的DBTL工作流中承接高通量DNA合成与蛋白表达的核心\"Build-Test\"环节,已获得订单验证,每轮迭代驱动客户复购合成服务形成正向循环。此外,公司此前上调全年营收指引至4.56亿至4.57亿美元,Q4营收指引1.23亿至1.24亿美元,大幅高于一致预期的1.174亿美元,强劲增长预期持续支撑股价走高。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘中上涨5.04%,AI赋能药物发现叙事叠加强劲营收指引持续推升股价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141351452","title":"异动解读|Twist Bioscience盘中上涨5.43%,营收指引大超预期推动股价高位震荡反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1141351452","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141351452?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:05","pubTimestamp":1786111508,"startTime":"0","endTime":"0","summary":"8月7日,Twist Bioscience盘中上涨5.43%,报114.465美元/股,成交额1851.88万美元。消息面上,公司此前公布财年第三季度业绩,营收录得1.184亿美元,同比增长23.2%,超出分析师预期的1.145亿美元。更为关键的是,公司上调全年营收指引至4.56亿至4.57亿美元,并预计第四季度营收1.23亿至1.24亿美元,大幅高于FactSet一致预期的1.174亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘中上涨5.43%,营收指引大超预期推动股价高位震荡反弹","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170260233","title":"异动解读|Twist Bioscience盘中下跌5.1%,财报多空分歧延续股价高位回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1170260233","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170260233?lang=zh_cn&edition=full","pubTime":"2026-08-07 03:29","pubTimestamp":1786044579,"startTime":"0","endTime":"0","summary":"8月7日,Twist Bioscience盘中下跌5.1%,报109.13美元/股,成交额1.2亿美元。公司上调全年营收指引至4.56亿至4.57亿美元,Q4营收指引1.23亿至1.24亿美元,均大幅高于一致预期的1.174亿美元。财报发布后股价经历剧烈多空博弈,8月3日一度下跌逾9%,随后因强劲营收指引反弹超6%。当前回调或反映市场在消化高估值与盈利恶化之间的持续博弈,此前Evercore ISI已于7月将公司评级下调至\"与大市持平\"。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152887709","title":"异动解读|Twist Bioscience盘中上涨6.59%,营收指引大超预期持续提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1152887709","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152887709?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:40","pubTimestamp":1785937257,"startTime":"0","endTime":"0","summary":"8月5日,Twist Bioscience盘中上涨6.59%,报109.6美元/股,成交额3481.74万美元。消息面上,公司此前公布财年第三季度业绩,营收录得1.184亿美元,同比增长23.2%,超出分析师预期的1.145亿美元。更为关键的是,公司上调全年营收指引至4.56亿至4.57亿美元,并预计第四季度营收1.23亿至1.24亿美元,大幅高于FactSet一致预期的1.174亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘中上涨6.59%,营收指引大超预期持续提振市场信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101007882","title":"异动解读|Twist Bioscience盘前上涨5.45%,营收指引大超预期提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1101007882","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101007882?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:12","pubTimestamp":1785935579,"startTime":"0","endTime":"0","summary":"8月5日,Twist Bioscience盘前上涨5.45%,报104.86美元/股,成交额96.2万美元。消息面上,公司此前公布财年第三季度业绩,营收录得1.184亿美元,同比增长23.2%,超出分析师预期的1.145亿美元。同时公司上调全年营收指引至4.56亿至4.57亿美元,并预计第四季度营收1.23亿至1.24亿美元,大幅高于FactSet一致预期的1.174亿美元。尽管每股亏损0.56美元不及市场预期,但强劲的收入增长势头及远超预期的前瞻指引持续提振投资者对公司业务扩张前景的信心,推动股价在盘前延续反弹走势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Twist Bioscience盘前上涨5.45%,营收指引大超预期提振市场信心","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183868177","title":"异动解读 | 业绩展望乐观,Twist Bioscience Corp盘中大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183868177","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183868177?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:10","pubTimestamp":1785766239,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp(TWST)今日盘中大涨5.16%,引发市场关注。消息面上,公司公布了第四季度业绩展望,预计总营收将介于约1.23亿美元至1.24亿美元之间。这一乐观的预期增强了投资者对公司业务运营状况的信心,从而推动了股价的盘中上扬。目前,市场正密切关注公司后续的业务进展及财务表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116521621","title":"异动解读|Twist Bioscience盘中下跌9.51%,财季业绩由盈转亏且超预期恶化","url":"https://stock-news.laohu8.com/highlight/detail?id=1116521621","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116521621?lang=zh_cn&edition=full","pubTime":"2026-08-03 21:39","pubTimestamp":1785764379,"startTime":"0","endTime":"0","summary":"8月3日,Twist Bioscience盘中下跌9.51%,报86.79美元/股,成交额2343.58万美元。消息面上,公司公布财年第三季度业绩,每股亏损0.56美元,去年同期为每股盈利0.33美元,业绩由盈转亏,且亏损幅度超出市场预期的0.51美元。营收方面,当季录得1.184亿美元,同比增长23.2%,超出分析师预期的1.145亿美元。公司同时上调全年营收指引至4.56亿至4.57亿美元,并预计第四季度营收1.23亿至1.24亿美元,均高于市场预期。此前Evercore ISI已于7月将公司评级从\"跑赢大盘\"下调至\"与大市持平\"。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Twist Bioscience盘中下跌9.51%,财季业绩由盈转亏且超预期恶化","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157710035","title":"异动解读 | 盈利由盈转亏且超预期恶化,Twist Bioscience盘前大跌6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157710035","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157710035?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:38","pubTimestamp":1785757093,"startTime":"0","endTime":"0","summary":"Twist Bioscience Corp(TWST)今日盘前股价大跌6.22%,引发市场关注。消息面上,公司公布了最新财季业绩。尽管营收同比增长23.2%至1.184亿美元,并超出分析师预期,同时公司上调了全年营收指引,但盈利端的表现拖累了股价。财报显示,公司当季每股亏损0.56美元,而去年同期为每股盈利0.33美元,业绩由盈转亏,且亏损幅度大于市场预期的每股亏损0.51美元。市场分析认为,尽管公司收入增长强劲且对未来指引乐观,但盈利能力的显著恶化成为投资者关注的焦点,对盈利端的担忧主导了本次盘前的抛售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185289808","title":"异动解读|Twist Bioscience盘前下跌6.22%,财季亏损超预期拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1185289808","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185289808?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:37","pubTimestamp":1785757024,"startTime":"0","endTime":"0","summary":"8月3日,Twist Bioscience盘前下跌6.22%,报85.86美元/股,成交额5.42万美元。消息面上,公司公布财年第三季度业绩,每股亏损0.56美元,较去年同期每股盈利0.33美元大幅恶化,且不及市场预期的亏损0.51美元。营收方面,当季录得1.184亿美元,同比增长23.2%,超出分析师预期的1.145亿美元。公司同时上调全年营收指引至4.56亿至4.57亿美元,并预计第四季度营收1.23亿至1.24亿美元,均高于市场预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience盘前下跌6.22%,财季亏损超预期拖累股价","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.twistbioscience.com","stockEarnings":[{"period":"1week","weight":-0.1178},{"period":"1month","weight":0.0844},{"period":"3month","weight":0.8018},{"period":"6month","weight":1.657},{"period":"1year","weight":3.8662},{"period":"ytd","weight":2.9319}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Twist Bioscience Corporation于2013年2月4日在特拉华州注册成立。该公司致力于为那些正在把世界变得更好的客户服务。在卫生保健、食品/农业、工业化学品、学术研究和数据存储等领域,客户正在利用他们的合成DNA工具开发改善生活和改善地球可持续性的方法。他们开发了一个颠覆性的DNA合成平台,使生物学工程产业化,为广泛的用途和市场提供DNA。他们将基于硅的DNA编写技术与专有软件、可伸缩的商业基础设施和电子商务平台结合起来,创建了一个集成的技术平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.077829},{"month":2,"riseRate":0.375,"avgChangeRate":-0.03419},{"month":3,"riseRate":0.375,"avgChangeRate":-0.060203},{"month":4,"riseRate":0.5,"avgChangeRate":-0.03729},{"month":5,"riseRate":0.75,"avgChangeRate":0.086916},{"month":6,"riseRate":1,"avgChangeRate":0.238398},{"month":7,"riseRate":0.625,"avgChangeRate":0.087317},{"month":8,"riseRate":0.25,"avgChangeRate":-0.006755},{"month":9,"riseRate":0.375,"avgChangeRate":-0.045118},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.015927},{"month":11,"riseRate":0.625,"avgChangeRate":0.212894},{"month":12,"riseRate":0.25,"avgChangeRate":0.020968}],"exchange":"NASDAQ","name":"Twist Bioscience Corp","nameEN":"Twist Bioscience Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Twist Bioscience Corp,TWST,Twist Bioscience Corp股票,Twist Bioscience Corp股票老虎,Twist Bioscience Corp股票老虎国际,Twist Bioscience Corp行情,Twist Bioscience Corp股票行情,Twist Bioscience Corp股价,Twist Bioscience Corp股市,Twist Bioscience Corp股票价格,Twist Bioscience Corp股票交易,Twist Bioscience Corp股票购买,Twist Bioscience Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Twist Bioscience Corp(TWST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Twist Bioscience Corp(TWST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}